ROGDI
Protein rogdi homolog
Also known as: FLJ22386, RAV2, ROGD1, ROGDI_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9GZN7
- Gene
- ROGDI
- Ensembl
- ENSG00000067836
- Chromosome
- 16
- Canonical length
- 287 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
OverviewNCBI Gene
Involved in brain development; neurogenesis; and odontogenesis of dentin-containing tooth. Located in nuclear envelope. Implicated in Kohlschutter-Tonz syndrome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
287 residues, UniProt reviewed canonical sequence.
>Q9GZN7|ROGDI
1 MATVMAATAA ERAVLEEEFR WLLHDEVHAV LKQLQDILKE ASLRFTLPGS GTEGPAKQEN
61 FILGSCGTDQ VKGVLTLQGD ALSQADVNLK MPRNNQLLHF AFREDKQWKL QQIQDARNHV
121 SQAIYLLTSR DQSYQFKTGA EVLKLMDAVM LQLTRARNRL TTPATLTLPE IAASGLTRMF
181 APALPSDLLV NVYINLNKLC LTVYQLHALQ PNSTKNFRPA GGAVLHSPGA MFEWGSQRLE
241 VSHVHKVECV IPWLNDALVY FTVSLQLCQQ LKDKISVFSS YWSYRPFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ROGDI can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 96 nTPM
Expression across tissuesHPA
Tissue
- hippocampal formation: 96 nTPM
- cerebral cortex: 90 nTPM
- basal ganglia: 87 nTPM
- spinal cord: 86 nTPM
- heart muscle: 80 nTPM
- cerebellum: 80 nTPM
Single-cell type
- oligodendrocytes: 95 nCPM
- brain excitatory neurons: 44 nCPM
- brain inhibitory neurons: 33 nCPM
- other brain neurons: 31 nCPM
- astrocytes: 21 nCPM
- ependymal cells: 18 nCPM
Immune cell
- classical monocyte: 75 nTPM
- intermediate monocyte: 63 nTPM
- non-classical monocyte: 62 nTPM
- myeloid DC: 62 nTPM
- total PBMC: 38 nTPM
- plasmacytoid DC: 35 nTPM
Brain region
- cerebral cortex: 114 nTPM
- white matter: 97 nTPM
- thalamus: 96 nTPM
- hippocampal formation: 86 nTPM
- midbrain: 73 nTPM
- medulla oblongata: 71 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ROGDI.
Disease | AllUniProt
Conditions ROGDI is implicated in, by any mechanism.
- Kohlschuetter-Toenz syndrome (KTZS) MIM:226750
Disease | GeneticClinVar
49 pathogenic / likely-pathogenic of 651 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Amelocerebrohypohidrotic syndrome
- Gastric cancer
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.42
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.32
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- bone mineralization
- brain development
- enamel mineralization
- gene expression
- hemopoiesis
- locomotion
- locomotor rhythm
- memory
- neurogenesis
- neuromuscular process
- odontogenesis of dentin-containing tooth
- pH reduction
- positive regulation of cell population proliferation
- response to xenobiotic stimulus
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RAVE subunit 2/Rogdi
- Rogdi leucine zipper containing protein
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ROGDI as an antibody target. Whether an autoantibody or antibody against ROGDI could matter depends on whether native ROGDI is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ROGDI is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ROGDI as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...